folder

The cellular and molecular cardiac tissue responses in human inflammatory cardiomyopathies after SARS-CoV-2 infection and COVID-19 vaccination

Authors

  • H. Maatz
  • E.L. Lindberg
  • E. Adami
  • N. López-Anguita
  • A. Perdomo-Sabogal
  • L. Cócera Ortega
  • G. Patone
  • D. Reichart
  • A. Myronova
  • S. Schmidt
  • A. Elsanhoury
  • O. Klein
  • U. Kühl
  • E. Wyler
  • M. Landthaler
  • S. Yousefian
  • S. Haas
  • F. Kurth
  • S.A. Teichmann
  • G.Y. Oudit
  • H. Milting
  • M. Noseda
  • J.G. Seidman
  • C.E. Seidman
  • B. Heidecker
  • L.E. Sander
  • B. Sawitzki
  • K. Klingel
  • P. Doeblin
  • S. Kelle
  • S. Van Linthout
  • N. Hubner
  • C. Tschöpe

Journal

  • Nature Cardiovascular Research

Citation

  • Nat Cardiovasc Res 4 (3): 330-345

Abstract

  • Myocarditis, characterized by inflammatory cell infiltration, can have multiple etiologies, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or, rarely, mRNA-based coronavirus disease 2019 (COVID-19) vaccination. The underlying cellular and molecular mechanisms remain poorly understood. In this study, we performed single-nucleus RNA sequencing on left ventricular endomyocardial biopsies from patients with myocarditis unrelated to COVID-19 (Non-COVID-19), after SARS-CoV-2 infection (Post-COVID-19) and after COVID-19 vaccination (Post-Vaccination). We identified distinct cytokine expression patterns, with interferon-γ playing a key role in Post-COVID-19, and upregulated IL16 and IL18 expression serving as a hallmark of Post-Vaccination myocarditis. Although myeloid responses were similar across all groups, the Post-Vaccination group showed a higher proportion of CD4(+) T cells, and the Post-COVID-19 group exhibited an expansion of cytotoxic CD8(+) T and natural killer cells. Endothelial cells showed gene expression changes indicative of vascular barrier dysfunction in the Post-COVID-19 group and ongoing angiogenesis across all groups. These findings highlight shared and distinct mechanisms driving myocarditis in patients with and without a history of SARS-CoV-2 infection or vaccination.


DOI

doi:10.1038/s44161-025-00612-6